 | • レポートコード：20QY06-01675 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、グルカゴンのグローバル市場について種類別（グルカゴン注射、鼻腔内グルカゴン）、用途別（救急キット、一般用、診断・運動性、心臓性ショック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・グルカゴン市場の概要 ・世界の主要地域別グルカゴン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のグルカゴン市場規模2015-2026：種類別（グルカゴン注射、鼻腔内グルカゴン） ・世界のグルカゴン市場規模2015-2026：用途別（救急キット、一般用、診断・運動性、心臓性ショック、その他） ・グルカゴンの北米市場規模2015-2020 ・グルカゴンのヨーロッパ市場規模2015-2020 ・グルカゴンの中国市場規模2015-2020 ・グルカゴンの日本市場規模2015-2020 ・グルカゴンの東南アジア市場規模2015-2020 ・グルカゴンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、Eli Lilly、Fresenius Kabi、Torrent Labs、Taj Pharmaceuticals、Xeris Pharmaceuticals） ・グルカゴンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・グルカゴンの市場動向・機会・課題 ・調査の結論 |
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.
Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and other field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.
North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Glucagon Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Glucagon market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Glucagon industry.
Based on our recent survey, we have several different scenarios about the Glucagon YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 491.6 million in 2019. The market size of Glucagon will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Glucagon Scope and Market Size
The global Glucagon market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glucagon market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glucagon market is segmented into
Inject Glucagon
Nasal Glucagon
Segment by Application, the Glucagon market is segmented into
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
The Glucagon market is analysed and market size information is provided by regions (countries). Segment by Application, the Glucagon market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glucagon Market Share Analysis
Glucagon market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glucagon business, the date to enter into the Glucagon market, Glucagon product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
…
1 Glucagon Market Overview
1.1 Glucagon Product Scope
1.2 Glucagon Segment by Type
1.2.1 Global Glucagon Sales by Type (2020-2026)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Segment by Application
1.3.1 Global Glucagon Sales Comparison by Application (2020-2026)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Glucagon Market Estimates and Forecasts (2015-2026)
1.4.1 Global Glucagon Sales Growth Rate (2015-2026)
1.4.2 Global Glucagon Revenue and Growth Rate (2015-2026)
1.4.3 Global Glucagon Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Glucagon Industry Impact
1.5.1 How the Covid-19 is Affecting the Glucagon Industry
1.5.1.1 Glucagon Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Glucagon Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Glucagon Players to Combat Covid-19 Impact
2 Glucagon Estimate and Forecast by Region
2.1 Global Glucagon Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Glucagon Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Glucagon Sales Market Share by Region (2015-2020)
2.2.2 Global Glucagon Revenue Market Share by Region (2015-2020)
2.3 Global Glucagon Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Glucagon Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Glucagon Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Glucagon Estimates and Projections (2015-2026)
2.4.2 Europe Glucagon Estimates and Projections (2015-2026)
2.4.3 China Glucagon Estimates and Projections (2015-2026)
2.4.4 Japan Glucagon Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Glucagon Estimates and Projections (2015-2026)
2.4.6 India Glucagon Estimates and Projections (2015-2026)
3 Global Glucagon Competition Landscape by Players
3.1 Global Top Glucagon Players by Sales (2015-2020)
3.2 Global Top Glucagon Players by Revenue (2015-2020)
3.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon as of 2019)
3.4 Global Glucagon Average Price by Company (2015-2020)
3.5 Manufacturers Glucagon Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Glucagon Players (Opinion Leaders)
4 Global Glucagon Market Size by Type
4.1 Global Glucagon Historic Market Review by Type (2015-2020)
4.1.1 Global Glucagon Sales Market Share by Type (2015-2020)
4.1.2 Global Glucagon Revenue Market Share by Type (2015-2020)
4.1.3 Global Glucagon Price by Type (2014-2020)
4.2 Global Glucagon Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Glucagon Sales Forecast by Type (2021-2026)
4.2.2 Global Glucagon Revenue Forecast by Type (2021-2026)
4.2.3 Global Glucagon Price Forecast by Type (2021-2026)
5 Global Glucagon Market Size by Application
5.1 Global Glucagon Historic Market Review by Application (2015-2020)
5.1.1 Global Glucagon Sales Market Share by Application (2015-2020)
5.1.2 Global Glucagon Revenue Market Share by Application (2015-2020)
5.1.3 Global Glucagon Price by Application (2015-2020)
5.2 Global Glucagon Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Glucagon Sales Forecast by Application (2021-2026)
5.2.2 Global Glucagon Revenue Forecast by Application (2021-2026)
5.2.3 Global Glucagon Price Forecast by Application (2021-2026)
3 North America Glucagon Market Facts & Figures
3.2 North America Glucagon Sales Market Share by Company (2015-2020)
3.3 North America Glucagon Sales Market Share by Type (2015-2020)
3.4 North America Glucagon Sales Market Share by Application (2015-2020)
4 Europe Glucagon Market Facts & Figures
4.2 Europe Glucagon Sales Market Share by Company (2015-2020)
4.3 Europe Glucagon Sales Market Share by Type (2015-2020)
4.4 Europe Glucagon Sales Market Share by Application (2015-2020)
5 China Glucagon Market Facts & Figures
5.2 China Glucagon Sales Market Share by Company (2015-2020)
5.3 China Glucagon Sales Market Share by Type (2015-2020)
5.4 China Glucagon Sales Market Share by Application (2015-2020)
6 Japan Glucagon Market Facts & Figures
6.2 Japan Glucagon Sales Market Share by Company (2015-2020)
6.3 Japan Glucagon Sales Market Share by Type (2015-2020)
6.4 Japan Glucagon Sales Market Share by Application (2015-2020)
7 Southeast Asia Glucagon Market Facts & Figures
7.2 Southeast Asia Glucagon Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Glucagon Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Glucagon Sales Market Share by Application (2015-2020)
8 India Glucagon Market Facts & Figures
8.2 India Glucagon Sales Market Share by Company (2015-2020)
8.3 India Glucagon Sales Market Share by Type (2015-2020)
8.4 India Glucagon Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Glucagon Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Glucagon Corporation Information
12.1.2 Novo Nordisk Glucagon Business Overview and Total Revenue
12.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk Glucagon Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Glucagon Corporation Information
12.2.2 Eli Lilly Glucagon Business Overview and Total Revenue
12.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly Glucagon Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Glucagon Corporation Information
12.3.2 Fresenius Kabi Glucagon Business Overview and Total Revenue
12.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Fresenius Kabi Glucagon Products Offered
12.3.5 Fresenius Kabi Recent Development
12.4 Torrent Labs
12.4.1 Torrent Labs Glucagon Corporation Information
12.4.2 Torrent Labs Glucagon Business Overview and Total Revenue
12.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Torrent Labs Glucagon Products Offered
12.4.5 Torrent Labs Recent Development
12.5 Taj Pharmaceuticals
12.5.1 Taj Pharmaceuticals Glucagon Corporation Information
12.5.2 Taj Pharmaceuticals Glucagon Business Overview and Total Revenue
12.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Taj Pharmaceuticals Glucagon Products Offered
12.5.5 Taj Pharmaceuticals Recent Development
12.6 Xeris Pharmaceuticals
12.6.1 Xeris Pharmaceuticals Glucagon Corporation Information
12.6.2 Xeris Pharmaceuticals Glucagon Business Overview and Total Revenue
12.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Xeris Pharmaceuticals Glucagon Products Offered
12.6.5 Xeris Pharmaceuticals Recent Development
…
13 Glucagon Manufacturing Cost Analysis
13.1 Glucagon Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glucagon
13.4 Glucagon Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glucagon Distributors List
14.3 Glucagon Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Glucagon Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Glucagon Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Glucagon Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Glucagon Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Glucagon Players to Combat Covid-19 Impact
Table 8. Global Market Glucagon Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Glucagon Sales (K MT) by Region (2015-2020)
Table 10. Global Glucagon Sales Market Share by Region (2015-2020)
Table 11. Global Glucagon Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Glucagon Revenue Share by Region (2015-2020)
Table 13. Global Glucagon Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Glucagon Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Glucagon Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Glucagon Revenue Share Forecast by Region (2021-2026)
Table 17. Global Glucagon (K MT) of Key Companies (2015-2020)
Table 18. Global Glucagon Sales Share by Company (2015-2020)
Table 19. Global Glucagon Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Glucagon Revenue Share by Company (2015-2020)
Table 21. Global Glucagon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon as of 2019)
Table 22. Global Glucagon Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Glucagon Manufacturing Sites and Area Served
Table 24. Manufacturers Glucagon Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Glucagon Players
Table 27. Global Glucagon Sales (K MT) by Type (2015-2020)
Table 28. Global Glucagon Sales Share by Type (2015-2020)
Table 29. Global Glucagon Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Glucagon Price (K MT) by Type (2015-2020)
Table 31. Global Glucagon Sales Share by Type (2021-2026)
Table 32. Global Glucagon Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Glucagon Revenue Share by Type (2021-2026)
Table 34. Global Glucagon Price (K MT) by Type (2021-2026)
Table 35. Global Glucagon Sales (K MT) by Application (2015-2020)
Table 36. Global Glucagon Sales Share by Application (2015-2020)
Table 37. Global Glucagon Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Glucagon Price (K MT) by Application (2015-2020)
Table 39. Global Glucagon Sales (K MT) by Application (2021-2026)
Table 40. Global Glucagon Sales Share by Application (2021-2026)
Table 41. Global Glucagon Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Glucagon Revenue Share by Application (2021-2026)
Table 43. Global Glucagon Price (K MT) by Application (2021-2026)
Table 44. United States Glucagon Sales (K MT) by Company (2015-2020)
Table 45. United States Glucagon Sales Market Share by Company (2015-2020)
Table 46. United States Glucagon Sales (K MT) by Type (2015-2020)
Table 47. United States Glucagon Sales Market Share by Type (2015-2020)
Table 48. United States Glucagon Sales (K MT) by Application (2015-2020)
Table 49. United States Glucagon Sales Market Share by Application (2015-2020)
Table 50. Europe Glucagon Sales (K MT) by Company (2015-2020)
Table 51. Europe Glucagon Sales Market Share by Company (2015-2020)
Table 52. Europe Glucagon Sales (K MT) by Type (2015-2020)
Table 53. Europe Glucagon Sales Market Share by Type (2015-2020)
Table 54. Europe Glucagon Sales (K MT) by Application (2015-2020)
Table 55. Europe Glucagon Sales Market Share by Type (2015-2020)
Table 56. China Glucagon Sales (K MT) by Company (2015-2020)
Table 57. China Glucagon Sales Market Share by Company (2015-2020)
Table 58. China Glucagon Sales (K MT) by Type (2015-2020)
Table 59. China Glucagon Sales Market Share by Type (2015-2020)
Table 60. China Glucagon Sales (K MT) by Application (2015-2020)
Table 61. China Glucagon Sales Market Share by Application (2015-2020)
Table 62. Japan Glucagon Sales (K MT) by Company (2015-2020)
Table 63. Japan Glucagon Sales Market Share by Company (2015-2020)
Table 64. Japan Glucagon Sales (K MT) by Type (2015-2020)
Table 65. Japan Glucagon Sales Market Share by Type (2015-2020)
Table 66. Japan Glucagon Sales (K MT) by Application (2015-2020)
Table 67. Japan Glucagon Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Glucagon Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Glucagon Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Glucagon Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Glucagon Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Glucagon Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Glucagon Sales Market Share by Application (2015-2020)
Table 74. India Glucagon Sales (K MT) by Company (2015-2020)
Table 75. India Glucagon Sales Market Share by Company (2015-2020)
Table 76. India Glucagon Sales (K MT) by Type (2015-2020)
Table 77. India Glucagon Sales Market Share by Type (2015-2020)
Table 78. India Glucagon Sales (K MT) by Application (2015-2020)
Table 79. India Glucagon Sales Market Share by Application (2015-2020)
Table 80. Novo Nordisk Corporation Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novo Nordisk Glucagon Product
Table 84. Novo Nordisk Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Eli Lilly Glucagon Product
Table 89. Eli Lilly Recent Development
Table 90. Fresenius Kabi Corporation Information
Table 91. Fresenius Kabi Description and Business Overview
Table 92. Fresenius Kabi Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Fresenius Kabi Glucagon Product
Table 94. Fresenius Kabi Recent Development
Table 95. Torrent Labs Corporation Information
Table 96. Torrent Labs Description and Business Overview
Table 97. Torrent Labs Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Torrent Labs Glucagon Product
Table 99. Torrent Labs Recent Development
Table 100. Taj Pharmaceuticals Corporation Information
Table 101. Taj Pharmaceuticals Description and Business Overview
Table 102. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Taj Pharmaceuticals Glucagon Product
Table 104. Taj Pharmaceuticals Recent Development
Table . Xeris Pharmaceuticals Corporation Information
Table . Xeris Pharmaceuticals Description and Business Overview
Table . Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Xeris Pharmaceuticals Glucagon Product
Table . Xeris Pharmaceuticals Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Glucagon Distributors List
Table 113. Glucagon Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Product Picture
Figure 2. Global Glucagon Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Glucagon Market Share by Application in 2020 & 2026
Figure 6. Emergency Kits Examples
Figure 7. General Use Examples
Figure 8. Diagnostic & Motility Examples
Figure 9. Cardiogenic Shock Examples
Figure 10. Others Examples
Figure 11. Global Glucagon Sales (K MT) Growth Rate (2015-2026)
Figure 12. Global Glucagon Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Glucagon Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 14. Global Glucagon Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Glucagon Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Glucagon Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Glucagon Sales (K MT) Growth Rate (2015-2026)
Figure 18. Europe Glucagon Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Glucagon Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Glucagon Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Glucagon Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Glucagon Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Glucagon Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Glucagon Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Glucagon Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Glucagon Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Glucagon Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Glucagon Players Market Share by Revenue in Glucagon 2015 & 2019
Figure 29. Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Glucagon Revenue Share by Type (2015-2020)
Figure 31. Global Glucagon Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Glucagon Revenue Share by Application (2015-2020)
Figure 33. Global Glucagon Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Glucagon Sales Market Share by Type in 2019
Figure 35. United States Glucagon Sales Market Share by Type in 2019
Figure 36. Europe Glucagon Sales Market Share by Company in 2019
Figure 37. Europe Glucagon Sales Market Share by Type in 2019
Figure 38. Europe Glucagon Sales Market Share by Application in 2019
Figure 39. China Glucagon Sales Market Share by Company in 2019
Figure 40. China Glucagon Sales Market Share by Type in 2019
Figure 41. China Glucagon Sales Market Share by Application in 2019
Figure 42. Japan Glucagon Sales Market Share by Company in 2019
Figure 43. Japan Glucagon Sales Market Share by Type in 2019
Figure 44. Japan Glucagon Sales Market Share by Application in 2019
Figure 45. Southeast Asia Glucagon Sales Market Share by Company in 2019
Figure 46. Southeast Asia Glucagon Sales Market Share by Type in 2019
Figure 47. Southeast Asia Glucagon Sales Market Share by Application in 2019
Figure 48. India Glucagon Sales Market Share by Company in 2019
Figure 49. India Glucagon Sales Market Share by Type in 2019
Figure 50. India Glucagon Sales Market Share by Application in 2019
Figure 51. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Torrent Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Xeris Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Glucagon
Figure 59. Manufacturing Process Analysis of Glucagon
Figure 60. Glucagon Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場レポート2020 A recently published report by QY Research titled Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistica…- バイオシミラーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.2% in the forecast period of 2020 to 2025 and will expected to reach USD 9643.4 million by 2025, from USD 5111 million in 2019. The Biosimilars market report…
- 使い捨て手術キットの世界市場レポート2020 Market Analysis and Insights: Global Disposable Surgical Kits Market The global Disposable Surgical Kits market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Disposable Surgical Kits Scope and Market Size The …
- アゼラスチン点鼻薬及びフルチカゾン点鼻薬の世界市場レポート2020 Azelastine and fluticasone combination nasal spray is used to treat an itchy or runny nose, sneezing, or other symptoms caused by seasonal hay fever (allergic rhinitis). Market Analysis and Insights: Global Azelastine-Fluticasone Nasal Market The global Azelastine-Fluticasone Nasal market was valued…
- ゾルミトリプタン点鼻薬の世界市場レポート2020 Market Analysis and Insights: Global Zolmitriptan Nasal Spray Market The global Zolmitriptan Nasal Spray market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Zolmitriptan Nasal Spray Scope and Market Size The …